Drug Prices

The price of prescription drugs has skyrocketed over the past several years. These price increases are extremely troublesome throughout the health care system.

Unchecked drug price increases are not sustainable, and are a serious economic threat to the patients and communities we serve. They not only threaten patient access to drug therapies, but challenge providers’ abilities to provide the highest quality of care.

Did you know?

  • In 2015, total spending on prescription drugs surpassed $457 billion
  • Spending on drugs rose 8.5% in 2015
  • The cost of some drugs jumped as much as 3,600% over two years

Hospitals bear a heavy financial burden when the cost of drugs increases. They are not only major purchasers of drugs, but patients often end up in the hospital when they cannot afford to take their medications as prescribed.

To that end, the American Hospital Association is proud to be a member of the Campaign for Sustainable Rx Pricing -– a diverse coalition of doctors, hospitals, pharmacists, employers, health plans, seniors, patients, consumers and others coming together to find common ground and solutions.

Moving forward, the AHA is committed to working for action on policies that foster transparency, competition and value while fostering innovation.

Read on to learn more about the impact of high drug pricing on patients and hospitals.

Related Resources

Testimony
Public
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions regarding “Effective Administration of the 340B Drug Pricing Program.”
Letter
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, and our clinician partners – including more than 270,000…
Letter
The American Hospital Association and others support Senators Grassley and Feinstein of the Senate Judiciary Committee for their leadership and com
Letter
Public
AHA comments to HRSA regarding proposed rule that would further delay the effective date for implementing final regulations regarding the 340B Drug Pricing…
Special Bulletin
Member
The Department of Health and Human Services, May 14, issued a policy statement and request for information (RFI) on ways to lower drug prices and reduce out-of…
Press Releases
Contact:  Marie Johnson, (202) 626-2351                Colin Milligan, (202) 638-5491